Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age

Clinical Science

Volumn 93, Issue 6, 1997, Pages 519-525

  Lyons, Declan ^a,c   Roy, Suzanne ^a   Patel, Mahesh ^b   Benjamin, Nigel ^b   Swift, Cameron G ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL LIMERICK   (Ireland)

Author keywords

Elderly; Nitric oxide; Noradrenaline; Plethysmography

Indexed keywords

CHOLESTEROL; GLUCOSE; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIET; DOSE RESPONSE; FEMALE; FOREARM; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MORBIDITY; PRIORITY JOURNAL; SENESCENCE; URINARY EXCRETION; VASCULAR ENDOTHELIUM; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 0030722166     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0930519     Document Type: Article

References (29)

1. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature (London) 1987; 327:524-6.
2. Yang Z, von Segesser L, Bauer E, Stultz P, Turina M, Luscher TF. Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. Circ Res 1991; 68: 52-60.
3. Moncada S, Radomski MW, Palmer RMJ. Endothelium derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988; 37: 2495-501.
4. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesise nitric oxide from L-arginine. Nature (London) 1988; 33: 664-6.
5. Vallance P, Collier J, Moncada S. Effects of endothelium derived nitric oxide on peripheral arteiolar tone in man. Lancet 1989; ii: 997-1000.
6. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (London) 1980; 288: 373-6.
7. G-monomethyl-i-arginine in patients with essential hypertension. J Hypertens 1994; 12: 1047-52.
8. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992; 10: 1025-31.
9. Zeiher AM, Drexter H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993; 92: 652-62.
10. Hongo K, Nakagomi T, Kassel NF, et al. Effects of aging and hypertension on endothelium-dependent vascular relaxation in rat carotid artery. Stroke 1988; 19: 892-7.
11. Winquist RJ, Bunting PB, Baskin EP, Wallace AA. Decreased endothelium-dependent relaxation in New Zealand genetic hypertensive rats. J Hypertens 1984; 2: 536-41.
12. Kung CF, Lüscher TF. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension 1995; 25: 194-200.
13. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-7.
14. Yasue H, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 1990; 81: 482-90.
15. Egashira K, Inou T, Hirooka Y, et al. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 1993; 88: 77-81.
16. Taddei S, Virdis A, Mattei P, et al. Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation 1995; 91: 1981-7.
17. Cockcroft JR, Benjamin N, Chowienczyk PJ, Ritter JM. Preserved endothelium dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330: 1036-40.
18. Panula P, Rechardt L. Age-dependent increase in the non-specific cholinesterase activity of the capillaries in the rat neostriatum. Histochemistry 1978; 55: 49-54.
19. G-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature. Br J Pharmacol 1993; 110: 736-8.
20. Whitney RJ. The measurement of volume changes in human limbs. J Physiol 1953; 121: 1-27.
21. Knight TM, Forman D, AI-Dabbagh SA, Doll R. Estimation of dietary intake of nitrate and nitrite in Great Britain. Food Chem Toxicol 1987; 4: 277-85.
22. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349: 837-42.
23. 15N]nitrate in biological fluids. Analytical Biochem 1982; 126: 131-8.
24. Greenfield ADM, Patterson GC. Reactions of the blood vessels of the human forearm to increases in transmural pressure. J Physiol 1954; 125: 508-24.
25. Elliott HL, Sumner DJ, McLean K, Reid JL. Effect of age on the responsiveness of vascular alpha-adrenoceptors in man. J. Cardiovasc Pharmacol 1982; 4: 388-92.
26. Wennmalm A, Benthin G, Edlund A, et al. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 1993; 73: 1121-7.
27. Mayhan WG, Faraci FM, Baumbach GL, Heistad DD. Effects of aging on responses of cerebral arterioles. Am J Physiol 1990; 258: H1138-43.
28. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium dependent vasodilation in experimental diabetes. J Clin Invest 1991; 87: 432-8.
29. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468-74.